Atrial septal defect 2

Networked: 13 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results


1. Rao, Ashwin L: 1 article (05/2015)
2. Zakrajsek, Rebecca A: 1 article (05/2015)
3. Larsen, Leslie K: 1 article (05/2015)
4. Drezner, Jonathan A: 1 article (05/2015)
5. Asif, Irfan M: 1 article (05/2015)
6. Harmon, Kimberly G: 1 article (05/2015)
7. Price, David: 1 article (05/2015)
8. Bejar, Matthew P: 1 article (05/2015)
9. Fisher, Leslee A: 1 article (05/2015)
10. Raabe, Johannes J: 1 article (05/2015)

Related Diseases

1. Patent Ductus Arteriosus
2. Mitral Valve Insufficiency (Mitral Regurgitation)
12/01/2009 - "Heart defects included left ventricular (LV) non-compaction (3), secundum atrial septal defect (2), muscular ventricular septal defect (1), dysplastic pulmonary valve without pulmonary stenosis (1) and mitral valve prolapse with mild mitral regurgitation (1). "
04/01/2000 - "However, echocardiography and Doppler studies identified 13 (3.6%) children (7 males and 6 females), with previously unknown cardiac abnormalities, as follows: abnormal mitral valve with mitral regurgitation (4), bicuspid aortic valve (2), atrial septal defect (2), coronary artery to pulmonary artery fistula (1), patent ductus arteriosus (1), pulmonary hypertension (1), cardiomyopathy (1), and pulmonary artery stenosis (1). "
04/01/1995 - "Although no epidemiological studies are available to evaluate the exact risk of infective endocarditis complicating native cardiac disease, analysis of data in the literature shows that cardiac disease can be classified into three groups of decreasing risk: (1) high risk disease includes cyanotic congenital heart lesions, previous bacterial endocarditis, aortic valve disease, mitral regurgitation and uncorrected left-to-right shunt, but not atrial septal defect; (2) cardiac conditions of moderate risk include mitral valve prolapse with valvar regurgitation or leaflet thickening, isolated mitral stenosis, tricuspid valve disease, pulmonary stenosis and hypertrophic cardiomyopathy; (3) conditions of low or no risk include isolated atrial septal defect, ischaemic heart disease and/or previous coronary artery bypass graft surgery, surgically corrected left-to-right shunt with no residual shunt, mitral valve prolapse with thin leaflets in the absence of regurgitation, and calcification of the mitral annulus."
3. Pathologic Constriction (Stenosis)
4. Cardiomyopathies (Cardiomyopathy)
5. Pulmonary Hypertension (Ayerza Syndrome)

Related Drugs and Biologics

1. Partial atrioventricular canal

Related Therapies and Procedures

1. Transplants (Transplant)
2. Coronary Artery Bypass (Coronary Artery Bypass Surgery)